Summary: The FDA has denied a citizen petition filed by a short seller challenging the safety and effectiveness of Wakix (pitolisant) for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy. The FDA reaffirmed Wakix’s favorable benefit-risk profile and … [Read more...]
Health Canada Approves Wakix for Pediatric Narcolepsy Patients
Wakix is the 1st Well being Canada-approved cure for youngsters 6 decades of age and older suffering from excessive daytime sleepiness or cataplexy indicators connected with narcolepsy. Paladin Labs Inc, a subsidiary of Endo International plc, announced Overall health Canada’s … [Read more...]